Learn more

TRASLATIONAL CANCER DRUGS PHARMA S L

Overview
  • Total Patents
    36
  • GoodIP Patent Rank
    220,002
About

TRASLATIONAL CANCER DRUGS PHARMA S L has a total of 36 patent applications. Its first patent ever was published in 2009. It filed its patents most often in EPO (European Patent Office), Australia and Mexico. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are BLUM KENNETH, CHI MEI FOUNDATION HOSPITAL and HARE JOSHUA M.

Patent filings per year

Chart showing TRASLATIONAL CANCER DRUGS PHARMA S Ls patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Lacal Sanjuan Juan Carlos 16
#2 Palacios Izquierdo Beatriz 7
#3 Van Hoogevest Peter 7
#4 L S Leigh Mathew 6
#5 Ramirez De Molina Ana 4
#6 Molina Ana Ramirez De 4
#7 Valdes Mora Fatima 4
#8 Sanjuan Juan Carlos Lacal 4
#9 Sanjuán Juan Carlos Lacal 3
#10 Gallego Ortega David 2

Latest patents

Publication Filing date Title
WO2013007808A1 Method for predicting outcome of cancer in a subject
WO2012175537A1 Method for predicting the clinical response to chemotherapy in a subject with cancer
BR112013028985A2 kiaa 1456 expression that predicts survival in colon cancer patients
EP2468259A1 Pharmaceutical compositions of pyridinium and quinolinium derivatives
EP2340042A2 Methods and compositions for the treatment of cancer
MX2011000147A Methods for the treatment and diagnosis of cancer.